Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
R. Navaridas, M. Vidal-Sabanes, A. Ruiz-Mitjana…·X. Dolcet
This study shows that simultaneous deletion of Pten and p53 in endometrial epithelial cells leads to epithelial to mesenchymal transition and the formation of uterine carcinosarcomas in vivo.
M. Lozano-Rabella, A. Garcia-Garijo, J. Palomero…·A. Gros
The paper investigates the immunogenicity of non-canonical HLA-I ligands from tumor cells and finds they are not recognized by autologous T-cells but can be targeted by donor T-cells, suggesting potential as immunotherapy targets.
C. Megino, X. Matias-Guiu, N. Eritja
This study shows ARID1A-deficient endometrial tumor cells reprogram the tumor microenvironment, promoting cancer progression and dissemination through chemokine secretion.
Y. Jung-Garcia, O. Maiques, I. Rodriguez-Hernandez…·J. G. Carlton
The paper identifies LAP1 as a regulator of nuclear plasticity that enables constrained migration in melanoma cells.
O. A. Romero, A. Villarrubi, J. J. Alburquerque-Bejar…·M. Sanchez-Cespedes
This study identifies KDM6A/UTX and KDM6B/JMJD3 as therapeutic targets in SMARCA4-deficient cancers, showing that their inhibition reduces tumor viability in mouse models.